UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Trends in Antimicrobial Drug Development: Implications for the Future

Clinical infectious diseases, 2004-05, Vol.38 (9), p.1279-1286

2004

Volltextzugriff (PDF)

Frequency of Poison Center Exposures for Pediatric Accidental Unsupervised Ingestions of Acetaminophen after the Introduction of Flow Restrictors

The Journal of pediatrics, 2018-07, Vol.198, p.254-259.e1

2018

Volltextzugriff (PDF)

Mitochondria as targets of drug toxicity: Lessons from the R118 phase I experience

Clinical pharmacology and therapeutics, 2015-11, Vol.98 (5), p.464-466

2015

Volltextzugriff (PDF)

Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal disease

Kidney international, 2004-02, Vol.65 (2), p.719-724

2004

Volltextzugriff (PDF)

Regulatory Pathways for New Antimicrobial Agents: Trade-offs to Keep the Perfect From Being the Enemy of the Good

Clinical pharmacology and therapeutics, 2016-12, Vol.100 (6), p.597-599

2016

Volltextzugriff (PDF)

Structured Frameworks to Increase the Transparency of the Assessment of Benefits and Risks of Medicines: Current Status and Possible Future Directions

Clinical pharmacology and therapeutics, 2015-11, Vol.98 (5), p.522-533

2015

Volltextzugriff (PDF)

Supplemental carnitine and exercise

The American journal of clinical nutrition, 2000-08, Vol.72 (2), p.618S-623S

BRASS, E. P

2000

Volltextzugriff (PDF)

Metabolic, idiosyncratic toxicity of drugs: overview of the hepatic toxicity induced by the anxiolytic, panadiplon

Chemico-biological interactions, 2001-05, Vol.134 (3), p.251-270

2001

Volltextzugriff (PDF)

Pivalate-generating prodrugs and carnitine homeostasis in man

Pharmacological reviews, 2002-12, Vol.54 (4), p.589-598

Brass, Eric P

2002

Volltextzugriff (PDF)

Medication Errors With Pediatric Liquid Acetaminophen After Standardization of Concentration and Packaging Improvements

Academic pediatrics, 2018-07, Vol.18 (5), p.563-568

2018

Volltextzugriff (PDF)

Carnitine and Sports Medicine: Use or Abuse?

Annals of the New York Academy of Sciences, 2004-11, Vol.1033 (1), p.67-78

BRASS, ERIC P.

2004

Volltextzugriff (PDF)

Changing the Status of Drugs from Prescription to Over-the-Counter Availability

The New England journal of medicine, 2001-09, Vol.345 (11), p.810-816

2001

Volltextzugriff (PDF)

Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia

Journal of vascular surgery, 2006-04, Vol.43 (4), p.752-759

2006

Volltextzugriff (PDF)

Impaired muscle oxygen use at onset of exercise in peripheral arterial disease

Journal of vascular surgery, 2004-09, Vol.40 (3), p.488-493

2004

Volltextzugriff (PDF)

Consumer behavior in the setting of over-the-counter statin availability: Lessons from the Consumer Use Study of OTC Mevacor

The American journal of cardiology, 2004-11, Vol.94 (9), p.22-29

Brass, Eric P.

2004

Volltextzugriff (PDF)

Synthetic Peptides That Exert Antimicrobial Activities in Whole Blood and Blood-Derived Matrices

Antimicrobial Agents and Chemotherapy, 2002-12, Vol.46 (12), p.3883-3891

2002

Volltextzugriff (PDF)

Carnitine metabolism during exercise

Life Sciences, 1994, Vol.54 (19), p.1383-1393

1994

Volltextzugriff (PDF)

Carnitine Replacement in End-Stage Renal Disease and Hemodialysis

Annals of the New York Academy of Sciences, 2004-11, Vol.1033 (1), p.52-66

2004

Volltextzugriff (PDF)

Label development and the label comprehension study for over-the-counter drugs

Clinical pharmacology and therapeutics, 2003-11, Vol.74 (5), p.406-412

2003

Volltextzugriff (PDF)

Analysis of Multiple End Points in Consumer Research in Support of Switching Drugs From Prescription to Over-the-Counter Status: The Concept of End-Point Hierarchies

Clinical pharmacology and therapeutics, 2009-04, Vol.85 (4), p.369-374

2009

Volltextzugriff (PDF)

Effect of Atorvastatin on Energy Expenditure and Skeletal Muscle Oxidative Metabolism at Rest and During Exercise

Clinical pharmacology and therapeutics, 2008-02, Vol.83 (2), p.243-250

2008

Volltextzugriff (PDF)

Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve Exercise capacity in hemodialysis patients

American journal of kidney diseases, 2001-05, Vol.37 (5), p.1018-1028

2001

Volltextzugriff (PDF)

Skeletal muscle metabolic changes in peripheral arterial disease contribute to exercise intolerance: a point-counterpoint discussion

Vascular medicine (London, England), 2004-11, Vol.9 (4), p.293-301

2004

Volltextzugriff (PDF)

Clinical trials for claudication : assessment of exercise performance, functional status, and clinical end points

Circulation (New York, N.Y.), 1995-08, Vol.92 (3), p.614-621

1995

Volltextzugriff (PDF)

Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease

Vascular medicine (London, England), 2000-02, Vol.5 (1), p.55-59

2000

Volltextzugriff (PDF)

1 – 25 von 121

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(92)

Publikationsform

Artikel
(119)
Tagungsberichte
(2)

Sprache

Englisch
(121)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

Science & Technology
(119)
Life Sciences & Biomedicine
(118)
Biological And Medical Sciences
(72)
Humans
(68)
Male
(64)
Medical Sciences
(50)
Animals
(47)
Rats
(40)
Pharmacology & Pharmacy
(36)
Pharmacology. Drug Treatments
(25)
Biochemistry & Molecular Biology
(23)
Fundamental And Applied Biological Sciences. Psychology
(23)
Middle Aged
(23)
Carnitine - Metabolism
(22)
Liver - Metabolism
(21)
Rats, Inbred Strains
(20)
Adult
(19)
Female
(19)
Aged
(18)
Liver - Drug Effects
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Trends in Antimicrobial Drug Development: Implications for the Future

Frequency of Poison Center Exposures for Pediatric Accidental Unsupervised Ingestions of Acetaminophen after the Introduction of Flow Restrictors

Mitochondria as targets of drug toxicity: Lessons from the R118 phase I experience

Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal disease

Regulatory Pathways for New Antimicrobial Agents: Trade-offs to Keep the Perfect From Being the Enemy of the Good

Structured Frameworks to Increase the Transparency of the Assessment of Benefits and Risks of Medicines: Current Status and Possible Future Directions

Supplemental carnitine and exercise

Metabolic, idiosyncratic toxicity of drugs: overview of the hepatic toxicity induced by the anxiolytic, panadiplon

Pivalate-generating prodrugs and carnitine homeostasis in man

Medication Errors With Pediatric Liquid Acetaminophen After Standardization of Concentration and Packaging Improvements

Carnitine and Sports Medicine: Use or Abuse?

Changing the Status of Drugs from Prescription to Over-the-Counter Availability

Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia

Impaired muscle oxygen use at onset of exercise in peripheral arterial disease

Consumer behavior in the setting of over-the-counter statin availability: Lessons from the Consumer Use Study of OTC Mevacor

Synthetic Peptides That Exert Antimicrobial Activities in Whole Blood and Blood-Derived Matrices

Carnitine metabolism during exercise

Carnitine Replacement in End-Stage Renal Disease and Hemodialysis

Label development and the label comprehension study for over-the-counter drugs

Analysis of Multiple End Points in Consumer Research in Support of Switching Drugs From Prescription to Over-the-Counter Status: The Concept of End-Point Hierarchies

Effect of Atorvastatin on Energy Expenditure and Skeletal Muscle Oxidative Metabolism at Rest and During Exercise

Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve Exercise capacity in hemodialysis patients

Skeletal muscle metabolic changes in peripheral arterial disease contribute to exercise intolerance: a point-counterpoint discussion

Clinical trials for claudication : assessment of exercise performance, functional status, and clinical end points

Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease

Suchergebnisse filtern